Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Congratulations to all of our finalists for 2019.
Our expert judges have assessed all the entries for the Global Generics & Biosimilars Awards 2019 to create the shortlist of Award finalists.
| Accord |
Pelgraz (pegylated filgrastim) |
| Arven Pharmaceuticals | Filgrastim prefilled syringe SC/IV infusion 30 miu/0.5 ml |
| mAbxience |
The expansion of bevacizumab worldwide |
| Sandoz | Agreement with Gan & Lee to commercialize and supply biosimilars of top three insulins |
| Shanghai Henlius Biotech | HLX01 (Rituximab Injection, Recombinant Human/Murine Chimeric Anti-CD20 Monoclonal Antibody Injection) |
| Stada |
Expansion of strategic biosimilar development partnership with Xbrane |
Acquisition of the Year
| Alvogen |
Exeltis product acquisition, including 23 brands |
| Aurobindo | Acquisition of dermatology and oral solids businesses from Sandoz |
| Eurofarma | Eurofarma reinforces its presence in Chile with the acquisition of Medipharm |
| Zentiva | Acquisition of Solacium Pharma (including Be Well Pharma) and Creo Pharma |
Leader of the Year
| Accord |
Binish Chudgar |
| Aurobindo | PV Ramprasad Reddy |
| Hikma | Siggi Olafsson |
| mAbxience | Emmanuelle Lepine |
| Stada | Peter Goldschmidt |
| Zentiva | Nick Haggar |
Industry Partner of the Year
Kit Check
Lambda Therapeutic Research
Pharmathen
Piramal Pharma Solutions
Rephine
West Pharma
Value Added Medicine Initiative of the Year
| Accord |
Methofill pre-filled syringe and SelfDose injector |
| Intas | Solifenacin orodispersible (fast-disintegrating) tablet |
| PharmEvo | Orodispersible powder with micro encapsulated iron |
| Stada | Anti-cancer drug bortezomib |
Business Development of the Year
| Accord |
Licensing of leuprorelin depot Injectable for global markets |
| Dr Reddy's | Engagement with clients through its no-boundary portal XCEED |
| PharmEvo | Orodispersible powder with micro encapsulated iron |
| Piramal Pharma Solutions | Patent challenge and launch of treatment for secondary hyperthyroidism |
| Stada | Expansion of strategic biosimilar development partnership with Xbrane |
| West Pharma |
The West AccelTRA elastomer components program |
Regulatory Achievement of the Year
| Alvogen |
Oral vinorelbine softgels |
| Insud Pharma-Chemo |
Duta Tamsu |
| Intas | Olmesartan/amlodipine/HCTZ fixed-dose combination |
| Lupin | Moxonidine tablets and valproate semisodium |
| Pharmathen | Long acting injectable (LAI) programs. |
| Sandoz | Generic approval under China’s QCE system |
Legal Strategy of the Year
| Accord & Aspire |
Challenge of the bimatoprost 0.01% patent in the UK |
| Alvogen | US Revlimid settlement / launch of a Suboxone rival |
| Dr Reddy's | Suboxone buprenorphine/naloxone sublingual films |
| Stada | Launch of anti-cancer drug bortezomib |
Corporate Social Responsibility (CSR) Initiative of the Year
| Accord |
Taking care of our environment, community and people |
| Dr Reddy's | Marking Integrated Transformation for Resourceful Agriculture (MITRA) |
| Hikma |
Dedicated to putting high-quality medicines in reach of patients |
| Insud Pharma |
Not a single baby with Chagas disease |
| Sandoz |
Sandoz HACk – Healthcare Access Challenge |
| Teva |
Increasing Access to Medicine |
For 2020 Sponsorship Opportunities contact:
Christopher Keeling
Tel: +44 (0) 7917 647 859
Email: christopher.keeling@informa.com
For all other enquiries:
Jo Kirkpatrick
Tel: +44 (0) 7917 555 986
Email: jo.kirkpatrick@informa.com
